Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 21
Phase 31

Trial Status

Completed1
Recruiting1
Other1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT06109558Phase 1/2Recruiting
The Efficacy and Safety of LMV-12 Combined With Osimertinib in NSCLC
EGF-R Positive Non-Small Cell Lung CancerMET AmplificationNon Small Cell Lung Cancer+1 more
PrincipalinvestigatorStart date: 2023-12-31
NCT02161991Phase 3Completed
Aprepitant for Chemotherapy Induced Nausea and Vomiting in Chinese Advanced Non-small Cell Lung Cancers
Carcinoma, Non-small Cell Lung
PrincipalinvestigatorStart date: 2014-02-01
NCT05673538Phase 1Unknown
TT-00973-MS Tablets in Patients With Advanced Solid Tumors
Advanced Solid Tumor
Principalinvestigator

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT06109558Phase 1/2PrincipalInvestigator

The Efficacy and Safety of LMV-12 Combined With Osimertinib in NSCLC

EGF-R Positive Non-Small Cell Lung CancerMET AmplificationNon Small Cell Lung Cancer+1 more
Recruiting
NCT02161991Phase 3PrincipalInvestigator

Aprepitant for Chemotherapy Induced Nausea and Vomiting in Chinese Advanced Non-small Cell Lung Cancers

Carcinoma, Non-small Cell Lung
Completed
NCT05673538Phase 1PrincipalInvestigator

TT-00973-MS Tablets in Patients With Advanced Solid Tumors

Advanced Solid Tumor
Unknown

All 3 trials loaded